|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-2-28
|
|
pubmed:abstractText |
Crohn's disease (CD) shows a chronic relapsing course but no marker of relapse is currently available. However, fecal alpha 1-antitrypsin (alpha 1-AT) clearance (alpha 1-ATCl) is an indicator of protein loss and increases during active inflammation. We assessed the usefulness of fecal alpha 1-ATCl in predicting clinical relapse in patients with inactive ileal CD.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0954-691X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
261-6
|
|
pubmed:dateRevised |
2009-10-16
|
|
pubmed:meshHeading |
pubmed-meshheading:12610321-Adult,
pubmed-meshheading:12610321-Biological Markers,
pubmed-meshheading:12610321-C-Reactive Protein,
pubmed-meshheading:12610321-Crohn Disease,
pubmed-meshheading:12610321-Feces,
pubmed-meshheading:12610321-Female,
pubmed-meshheading:12610321-Humans,
pubmed-meshheading:12610321-Male,
pubmed-meshheading:12610321-Middle Aged,
pubmed-meshheading:12610321-Predictive Value of Tests,
pubmed-meshheading:12610321-Prospective Studies,
pubmed-meshheading:12610321-Recurrence,
pubmed-meshheading:12610321-Sensitivity and Specificity,
pubmed-meshheading:12610321-alpha 1-Antitrypsin
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum.
|
|
pubmed:affiliation |
Cattedra di Gastroenterologia, Dipartimento di Medicina Interna, Università degli Studi di Roma Tor Vergata, Rome, Italy. biancone@med.uniroma1.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
